If you liked this article you might like

4 Stocks Under $10 Setting Up to Break Out
Is This The Best Biotech Play for 2017?
Opko Health, FireEye, KBR: 'Mad Money' Lightning Round
Don't Be Cowed in the Face of This Bull: Cramer's 'Mad Money' Recap (Wednesday March 1)